[go: up one dir, main page]

FR3121577B1 - Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process - Google Patents

Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process Download PDF

Info

Publication number
FR3121577B1
FR3121577B1 FR2103745A FR2103745A FR3121577B1 FR 3121577 B1 FR3121577 B1 FR 3121577B1 FR 2103745 A FR2103745 A FR 2103745A FR 2103745 A FR2103745 A FR 2103745A FR 3121577 B1 FR3121577 B1 FR 3121577B1
Authority
FR
France
Prior art keywords
control products
composition
implementation
manufacture
analyzes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2103745A
Other languages
French (fr)
Other versions
FR3121577A1 (en
Inventor
Christelle Sache
Anthony Ciochetto
Emmanuelle Reverbel
Laurent Daels
Stefan Lamouroux
Gérard Marie Papierok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elitech Microbio
Original Assignee
Elitech Microbio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elitech Microbio filed Critical Elitech Microbio
Priority to FR2103745A priority Critical patent/FR3121577B1/en
Publication of FR3121577A1 publication Critical patent/FR3121577A1/en
Application granted granted Critical
Publication of FR3121577B1 publication Critical patent/FR3121577B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L’invention concerne une composition stabilisante destinée à être utilisée dans le cadre d’un procédé de traitement et de stabilisation des cellules d’eucaryotes pour la fabrication et la réalisation d’échantillons ou de produits de contrôles, destinés aux laboratoires d’analyses médicales ou vétérinaires pour les diverses analyses de prélèvements biologiques issus de l’homme et/ou de l’animal, et en particulier de prélèvements de liquides biologiques (sang, urine, liquides d’épanchement, etc.), le procédé de traitement et de stabilisation desdites cellules utilisant ladite composition, et les produits de contrôle issus de la mise en œuvre dudit procédé.The invention relates to a stabilizing composition intended to be used as part of a process for treating and stabilizing eukaryotic cells for the manufacture and production of samples or control products intended for medical analysis laboratories. or veterinarians for the various analyzes of biological samples from humans and/or animals, and in particular samples of biological fluids (blood, urine, effusion fluids, etc.), the process of treatment and stabilization of said cells using said composition, and the control products resulting from the implementation of said process.

FR2103745A 2021-04-12 2021-04-12 Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process Active FR3121577B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2103745A FR3121577B1 (en) 2021-04-12 2021-04-12 Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2103745 2021-04-12
FR2103745A FR3121577B1 (en) 2021-04-12 2021-04-12 Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process

Publications (2)

Publication Number Publication Date
FR3121577A1 FR3121577A1 (en) 2022-10-14
FR3121577B1 true FR3121577B1 (en) 2024-03-08

Family

ID=76034807

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2103745A Active FR3121577B1 (en) 2021-04-12 2021-04-12 Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process

Country Status (1)

Country Link
FR (1) FR3121577B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551208C3 (en) 1975-11-14 1981-05-27 Behringwerke Ag, 3550 Marburg Process for the production of a stable erythrocyte preparation
US4412004A (en) 1981-06-26 1983-10-25 Technicon Instruments Corporation Method for treating red blood cells to effect sphering and reagent therefor
US4579824A (en) 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
JP2003508586A (en) 1999-08-27 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー Fast acting formulation ingredients, compositions using those ingredients and washing methods
US7267980B1 (en) * 2003-04-04 2007-09-11 Research & Diagnostic Systems, Inc. Stabilizing solution for cells and tissues
CN111413176B (en) * 2020-05-09 2023-05-16 河北艾驰生物科技有限公司 Erythrocyte and leucocyte quality control substance for urine component analysis and preparation method thereof

Also Published As

Publication number Publication date
FR3121577A1 (en) 2022-10-14

Similar Documents

Publication Publication Date Title
Möllerherm et al. Antimicrobial activity of mast cells: role and relevance of extracellular DNA traps
Li et al. Neutrophils self-regulate immune complex-mediated cutaneous inflammation through CXCL2
Black et al. Current concepts regarding the effect of wound microbial ecology and biofilms on wound healing
MA47399B1 (en) Derivatives of 7-phenylethylamino-4h-pyrimido [4,5-d] [1,3] oxazin-2-one as inhibitors of the mutated form of idh1 and idh2 proteins
Martínez et al. Mitofusins modulate the increase in mitochondrial length, bioenergetics and secretory phenotype in therapy-induced senescent melanoma cells
Ashraf et al. Ivermectin binds to Haemonchus contortus tubulins and promotes stability of microtubules
Trybek et al. Impact of lactoferrin on bone regenerative processes and its possible implementation in oral surgery–a systematic review of novel studies with metanalysis and metaregression
Wagner et al. Surgical debridement is superior to sole antibiotic therapy in a novel murine posttraumatic osteomyelitis model
FR3121577B1 (en) Stabilizing composition, process using said composition for the manufacture of control products for analyzes of biological samples in mammals, and control products resulting from the implementation of said process
FR3117846B1 (en) DISPERSION COMPRISING A POLYMERIC PARTICLE, A STABILIZING AGENT WITH A C9-C22 ALKYL GROUP, AN OIL AND WATER, PROCESS FOR THE TREATMENT OF KERATIN MATERIALS USING THE DISPERSION
MX2021009660A (en) COMPOSITION THAT INCLUDES A MIXTURE OF DNA MOLECULES, THEIR USES AS A BIOLOGICAL INHIBITOR AND METHOD FOR PRODUCTION.
Qadeer et al. Role of ibuprofen and lavender oil to alter the stress induced psychological disorders: A comparative study.
EP3845516A4 (en) NEW HIF-1alfa INHIBITOR, METHOD FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ANGIOGENESIS-ASSOCIATED EYE DISEASE, CONTAINING THE SAME AS AN ACTIVE INGREDIENT
MX2021008507A (en) Lilrb3-binding molecules and uses therefor.
De Vecchi et al. Improving the bacterial recovery by using dithiothreitol with aerobic and anaerobic broth in biofilm-related prosthetic and joint infections
Hendrijantini et al. Human umbilical cord mesenchymal stem cells induction in peri-implantitis Rattus norvegicus accelerates and enhances osteogenesis activity and implant osseointegration
Cotticelli et al. Identification of a novel oleic acid analog with protective effects in multiple cellular models of Friedreich ataxia
Bartel et al. Caspase-6 mediates resistance against Burkholderia pseudomallei infection and influences the expression of detrimental cytokines
Lorenzo et al. Map of ethical conflicts of the CRISPR-Cas9 gene edition technique
Anisimov et al. Improvement of careesprophylaxic gel composition
Matysik et al. Cytotoxic action of hepatoprotector Antral on bull sperm
Lawrence et al. CLASPs stabilize the intermediate state between microtubule growth and catastrophe
Polunina et al. Escherichia coli and Micrococcus luteus Activate the CG45045 Gene in Drosophila S2 Cell Line
Wu et al. dock8 deficiency attenuates microglia colonization in early zebrafish larvae
Guryleva Ethical review of preclinical research

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20221014

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5